Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Invasive Fungal Infections 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Meropenem 6Ceftazidime 5Vancomycin 4Ciprofloxacin 3Cefepime 3Teicoplanin 2Levofloxacin 2Amikacin 2ceftolozane, tazobactam drug combination 1Vaccination 1Tazobactam 1Simvastatin 1Pneumococcal Vaccines 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Ofloxacin 1Micafungin 1Metronidazole 1Injections 1Filgrastim 1Cilastatin, Imipenem Drug Combination 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Febrile Neutropenia × Micafungin × Clear all
NCT05784844 2024-09-19

Antimicrobial Revision in Persistent Febrile Neutropenia

Wake Forest University Health Sciences

Phase 4 Withdrawn
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡